ProQR Therapeutics N.V. PRQR · SEC Filings

website

166

ProQR Therapeutics N.V. operates as a biopharmaceutical enterprise dedicated to discovering and deve...

Price1.38

Market Cap199.94 M

Float110.2 M

CountryNL

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

6-K/A

Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]

Oct 30, 2026

6-K

ProQR to Present Clinical and Preclinical Progress from AX-0810 and AX-0811 at Upcoming Conferences

Oct 28, 2026

6-K

ProQR Appoints Chris Hart as Chief Data and AI Officer and Thomas Wolf to Board as Strategic AI Advisor

Sep 23, 2026

6-K

ProQR Doses First Participant in Phase 1 Trial of AX-0811 for Cholestatic Liver Diseases

Sep 9, 2026

6-K

ProQR Therapeutics N.V. Reports Financial Results for the Six Months Ended June 30, 2026

Aug 13, 2026

6-K

ProQR Therapeutics Reports Q2 2026 Financial Results and Clinical Progress

Aug 13, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

SHARE RESALE REGISTRATION | Shares: 3,030,303

Jul 15, 2026

424B5

REGISTERED OFFERING

Jun 25, 2026

424B5

SHARE RESALE

Mar 25, 2025

424B5

SHELF OFFERING | Shares amount: 18,000,000 | Share price: $3.50 | Offering amount: $63,000,000.00 | Bank: Evercore ISI, Cantor, Raymond James, Oppenheimer & Co.

Oct 24, 2024

424B5

PENDING OFFERING | Bank: Evercore ISI, Cantor, Raymond James, Oppenheimer & Co.

Oct 23, 2024

424B5

ATM | Offering amount: $75,000,000

Oct 10, 2024

Registrations

TYPE

HEADLINE

FILED AT

F-3

SHARE RESALE REGISTRATION

Jul 6, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 13, 2025

F-3

Form F-3 - Registration statement by foreign private issuers

Mar 13, 2025

F-3

SHELF | ATM | Offering amount: $300,000,000.00 EFFECTIVE, DATED 2024-10-10

Sep 30, 2024

Registration

Mar 29, 2023

F-3

SHARE RESALE REGISTRATION | Shares amount: 13,371,562 | Share price: $3.42 EFFECTIVE

Mar 29, 2023

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

de Boer Daniel Anton (Reporting)

Aug 3, 2026

SCHEDULE 13D/A

VAN HERK INVESTMENTS B.V. (Filed by)

Jul 29, 2026

SCHEDULE 13G

Aberdeen Group plc (Filed by)

Jul 29, 2026

SCHEDULE 13G/A

ELI LILLY & Co (Filed by)

Jul 24, 2026

Filius Bart (Reporting)

Jul 21, 2026

SCHEDULE 13G/A

Privium Fund Management B.V. (Filed by)

Jul 15, 2026

Other

TYPE

HEADLINE

FILED AT